Background Circle Background Circle
GHB: Killer drug to be made a Class B substance

GHB: Killer drug to be made a Class B substance

It was used in attacks by the UK’s most prolific rapist and the serial killer Stephen Port.

Source link

You Might Also Like!
Britain must diet, say top health officials: BBC News Review
Britain must diet, say top health officials: BBC News Review

Health officials have called on the food industry to cut the calorie content of their products to help combat obesity. ENGAGE+

2020 Science News – A Year in Review
2020 Science News – A Year in Review

A review of the biggest science news stories of 2020. Patreon: https://www.patreon.com/biologicpodcast Official Store: ... source

Coronavirus treatment breakthrough “will save thousands of lives" – BBC News
Coronavirus treatment breakthrough “will save thousands of lives" – BBC News

The first medicine that's been proven to reduce deaths among people infected with coronavirus is expected to save thousands of ENGAGE+

Common Prostate Drug May Help Prevent Parkinson's
Common Prostate Drug May Help Prevent Parkinson's

By Cara Murez HealthDay ReporterMONDAY, Feb. 8, 2021 (HealthDay News) -- While scientists still don't know what causes Parkinson's disease, ENGAGE+

New Drug Combo Could Help Treat Uterine Fibroids
New Drug Combo Could Help Treat Uterine Fibroids

For their trial, Al-Hendy and his colleagues recruited 770 women from several countries, including the United States. All had heavy ENGAGE+

Fewer Illicit Drug Seizures Seen During Lockdowns
Fewer Illicit Drug Seizures Seen During Lockdowns

FRIDAY, March 5, 2021 (HealthDay News) -- Seizures of illegal drugs fell sharply in the United States during early COVID-19 ENGAGE+

Experimental Drug May Fight Type 1 Diabetes
Experimental Drug May Fight Type 1 Diabetes

By Amy Norton HealthDay ReporterMONDAY, March 8, 2021 (HealthDay News) -- Just two weeks of treatment with an experimental drug ENGAGE+

New Alzheimer's Drug Slows Cognitive Decline in Early Test
Common Prostate Drug May Help Prevent Parkinson's

March 15, 2021 -- An experimental drug appeared to slow cognitive decline in people with early Alzheimer’s disease, according to ENGAGE+